Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,861 | -18,331 | -80,403 | -40,119 | -25,020 |
| Depreciation Amortization | 1,035 | 520 | 1,639 | 1,267 | 851 |
| Accounts payable and accrued liabilities | 911 | 592 | -1,028 | -561 | -15 |
| Other Working Capital | -3,549 | -865 | 13,008 | -3,662 | -3,293 |
| Other Operating Activity | 29,797 | 7,103 | 37,231 | 7,229 | 2,848 |
| Operating Cash Flow | $-23,667 | $-10,981 | $-29,553 | $-35,846 | $-24,629 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -129 | N/A | -243 | -243 | -279 |
| Investing Cash Flow | $-129 | $N/A | $-243 | $-243 | $-279 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -208 | -190 | -79 |
| Common Stock Issued | 61 | 57 | 61,168 | 32,565 | N/A |
| Other Financing Activity | 0 | 0 | 14,930 | 14,930 | 0 |
| Financing Cash Flow | $61 | $57 | $75,890 | $47,305 | $-79 |
| Beginning Cash Position | 111,757 | 111,757 | 65,663 | 65,663 | 65,663 |
| End Cash Position | 88,022 | 100,833 | 111,757 | 76,879 | 40,676 |
| Net Cash Flow | $-23,735 | $-10,924 | $46,094 | $11,216 | $-24,987 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,667 | -10,981 | -29,553 | -35,846 | -24,629 |
| Capital Expenditure | -129 | N/A | -279 | -279 | -279 |
| Free Cash Flow | -23,796 | -10,981 | -29,832 | -36,125 | -24,908 |